FCHI8,141.92-0.19%
GDAXI24,083.53-0.19%
DJI49,105.99-0.25%
XLE56.78-0.17%
STOXX50E5,860.32-0.39%
XLF51.780.71%
FTSE10,321.09-0.56%
IXIC24,761.37-0.30%
RUT2,784.49-0.09%
GSPC7,155.26-0.14%
Temp29.1°C
UV7.7
Feels33.1°C
Humidity62%
Wind14.8 km/h
Air QualityAQI 1
Cloud Cover25%
Rain0%
Sunrise06:00 AM
Sunset06:47 PM
Time10:54 AM
DHRNYQHealthcare·Diagnostics & Research#2 in industry

Danaher Corporation

Reports in 85d· 2026-07-21
$180.43
+3.18 (+1.79%)

News

(3)

April 2026

4 days ago424B5Healthcare

Danaher Raises €3 Billion in Bonds to Fund Masimo Acquisition

DHRDANAHER CORP /DE/

# 🧾 What This Document Is This is a **prospectus supplement** filed with the SEC. It’s a legal document that provides the specific details for a new bond offering by Danaher Corporation. Think of it as the detailed menu and terms for a big loan the company is taking out. It updates a broader pros

Read summaryView on SEC EDGAR
5 days ago424B5Healthcare

Danaher (DHR) issues debt for proposed Masimo acquisition funding

DHRDANAHER CORP /DE/

# 📄 What This Document Is 📝 This document is a preliminary prospectus supplement filed by Danaher Corporation (DHR). Think of it as a detailed pre-sale guidebook for a massive debt offering. Since this is a "supplement," it adds specific information about the new bonds (notes) being sold to a muc

Read summaryView on SEC EDGAR
6 days ago8-KHealthcare

DHR announces Masimo acquisition and raises full-year guidance for 2026

DHRDANAHER CORP /DE/

# 📜 What This Document Is 🗓️ This report summarizes Danaher Corporation's (DHR) results for the first quarter of 2026, filed as an 8-K with the SEC. This type of filing is used to announce major corporate events or periodic results to the public immediately. The filing contains the company's fina

Read summaryView on SEC EDGAR

Peers in Diagnostics & Research